B53 | Adverse perinatal outcomes associated with timing of initiation of antiretroviral therapy: systematic review and meta-analysis | E-poster | Pregnancy (clinical management issues and pharmacokinetics) |
B53 | Comparable pregnancy outcomes for HIV-uninfected and HIV-infected women on antiretroviral treatment in Kenya | E-poster | Pregnancy (clinical management issues and pharmacokinetics) |
B53 | A comparative multi-country analysis of the impact of COVID-19 on HIV services for pregnant and breastfeeding women and their infants | E-poster | Pregnancy (clinical management issues and pharmacokinetics) |
B55 | Hormonal contraception is associated with increased risk of cardiometabolic disease in women living with HIV | E-poster | Contraception |
B57 | Retention on antiretroviral treatment (ART) six and 18 months after delivery in women living with HIV (WL-HIV), in Brazil, 2010-2017 | E-poster | Other sex- or gender-specific issues |
B58 | Relationship of the haematological profile with the viral load and clinical staging of HIV infected children at the Obafemi Awolowo university teaching hospitals complex (OAUTHC), Ile-Ife, Osun state, Nigeria | E-poster | Diagnosis of HIV disease in paediatric and adolescent populations |
B58 | Plasma IP-10 concentrations show no correlation with HIV infection in children attending hospitals in Blantyre and Mulanje, Malawi | E-poster | Diagnosis of HIV disease in paediatric and adolescent populations |
B59 | No age-related difference in dolutegravir metabolic glucuronidation ratio in children between 3 months and 18 years old in the ODYSSEY trial | E-poster | Pharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations |
B59 | Expected impact of malnutrition on first-line antiretroviral drug exposure in a global population of children in countries with highest child mortality: a quantitative modeling and simulation study | E-poster | Pharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations |
B60 | Assessing parental choice of lopinavir/ritonavir granules intake to improve child adherence at Baylor-Mwanza, Tanzania | E-poster | Drug formulations for infants and children |